Related references
Note: Only part of the references are listed.Long-term follow-up of post-cardiac surgery Mycobacterium chimaera infections: A 5-center case series
Kathleen G. Julian et al.
JOURNAL OF INFECTION (2020)
Pharmacologic management of Mycobacterium ulcerans infection
Tjip S. van der Werf et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous Mycobacteria
Suzanne S. Stokes et al.
ACS INFECTIOUS DISEASES (2020)
Toward a Single-Dose Cure for Buruli Ulcer
Sangeeta S. Thomas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
Aurelie Chauffour et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay
Paul J. Converse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
Paul J. Converse et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Buruli Ulcer: a Review of the Current Knowledge
Rie R. Yotsu et al.
CURRENT TROPICAL MEDICINE REPORTS (2018)
Mycobacterium chimaera Spread from Heating and Cooling Units in Heart Surgery
Deborah Williamson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Complete Genome Sequence of Mycobacterium chimaera SJ42, a Nonoutbreak Strain from an Immunocompromised Patient with Pulmonary Disease
Nabeeh A. Hasan et al.
GENOME ANNOUNCEMENTS (2017)
A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
Christopher P. Locher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis
Shahul P. Hameed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability
Anne-Laure Grillot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Activities of Moxifloxacin in Combination with Macrolides against Clinical Isolates of Mycobacterium abscessus and Mycobacterium massiliense
Go-Eun Chol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis
Sidharth Chopra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Comparative genomic and phylogeographic analysis of Mycobacterium leprae
Marc Monot et al.
NATURE GENETICS (2009)
Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis
Timothy P. Stinear et al.
GENOME RESEARCH (2008)
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: Intelligent design and evolution through the judicious use of structure-guided design and stucture-activity relationships
Paul S. Charifson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer
Timothy P. Stinear et al.
GENOME RESEARCH (2007)
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans
Baohong Ji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mycobacterium ulcerans infection:: control, diagnosis, and treatment
V Sizaire et al.
LANCET INFECTIOUS DISEASES (2006)
Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp nov.
E Tortoli et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2004)